128 related articles for article (PubMed ID: 10561944)
21. [HIV-1 transmission from mother to child and its prevention].
Le Coeur S; Kanshana S; Jourdain G
Med Trop (Mars); 2003; 63(4-5):381-90. PubMed ID: 14763292
[TBL] [Abstract][Full Text] [Related]
22. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
23. Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.
Phuapradit W; Sirinavin S; Taneepanichskul S; Chaovavanich A; Wiratchai A; Sunthornkachit R; Puchaiwatanon O
Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):288-92. PubMed ID: 9761155
[TBL] [Abstract][Full Text] [Related]
24. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.
Coetzee D; Hilderbrand K; Boulle A; Draper B; Abdullah F; Goemaere E
Bull World Health Organ; 2005 Jul; 83(7):489-94. PubMed ID: 16175822
[TBL] [Abstract][Full Text] [Related]
26. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
Pinkerton SD; Holtgrave DR; Layde PM
Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
[TBL] [Abstract][Full Text] [Related]
27. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
29. [Mother-to-child transmission of HIV infections. Antiviral agents and Cesarean section reduce the risk of transmission].
Bohlin AB; Lindgren S; Lidman K; Sönnerborg A
Lakartidningen; 2000 Jul; 97(28-29):3275-9. PubMed ID: 10997016
[TBL] [Abstract][Full Text] [Related]
30. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
31. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
Scarlatti G
AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
[TBL] [Abstract][Full Text] [Related]
32. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
33. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
[TBL] [Abstract][Full Text] [Related]
34. Global strategies for the prevention of vertical HIV transmission.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):18-27. PubMed ID: 11364942
[TBL] [Abstract][Full Text] [Related]
35. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
[TBL] [Abstract][Full Text] [Related]
36. [Treatment failure of preventive zidovudine in maternal fetal transmission of HIV].
Wirtgen P; Pons JC; Boubon MC; Taburet AM; Delfraissy JF; Horovitz J
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):289-92. PubMed ID: 8102148
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States.
Burger H; Kovacs A; Weiser B; Grimson R; Nachman S; Tropper P; van Bennekum AM; Elie MC; Blaner WS
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(4):321-6. PubMed ID: 9111473
[TBL] [Abstract][Full Text] [Related]
38. [Preliminary study on the transport of AZT (Retrovir-zidovudine) through the placenta].
Gillet JY; Bongain A; Abrar D; Garraffo R; Lapalus P
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):177-80. PubMed ID: 2324439
[TBL] [Abstract][Full Text] [Related]
39. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
[TBL] [Abstract][Full Text] [Related]
40. Zidovudine pharmacokinetics during pregnancy.
Sperling RS; Roboz J; Dische R; Silides D; Holzman I; Jew E
Am J Perinatol; 1992 Jul; 9(4):247-9. PubMed ID: 1627212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
